Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways

BACKGROUND: Resveratrol (RSV) has attracted interest as an alternative drug for the treatment of acute lung injury (ALI) and other pulmonary diseases, but its poor oral bioavailability is a limitation. In this study, we employed drug delivery nanotechnology to improve the stability, lung localizatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: de Oliveira, Maria Talita Pacheco, de Sá Coutinho, Diego, Tenório de Souza, Éverton, Stanisçuaski Guterres, Sílvia, Pohlmann, Adriana Raffin, Silva, Patricia Machado Rodrigues, Martins, Marco Aurélio, Bernardi, Andressa
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636190/
https://ncbi.nlm.nih.gov/pubmed/31371957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S200666
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars